Cargando…
The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis
INTRODUCTION: Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). Although gender has not been included in prognostic systems, male gender has been found as a bad prognostic indicator in Hodgkin lymphoma, follicular lymphoma and chronic lymphocytic leukemi...
Autores principales: | Yıldırım, Mustafa, Kaya, Vildan, Demirpençe, Özlem, Paydaş, Semra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548028/ https://www.ncbi.nlm.nih.gov/pubmed/26322081 http://dx.doi.org/10.5114/aoms.2015.53289 |
Ejemplares similares
-
Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis
por: Ren, Yuan-Rong, et al.
Publicado: (2015) -
Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis
por: Yuan, Ting, et al.
Publicado: (2021) -
Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Hatami, Hossein, et al.
Publicado: (2022) -
Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Wang, Ling, et al.
Publicado: (2019) -
Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)